Transdermal Peptide Disulfide (TFA)

Transdermal Peptide Disulfide (TFA)

• UNSPSC Description: Transdermal Peptide Disulfide TFA (TD 1 Disulfide(peptide) TFA) is a 11-amino acid peptide, binds to Na+/K+-ATPase beta-subunit (ATP1B1), and mainly interacts with the C-terminus of ATP1B1. Transdermal Peptide Disulfide TFA can enhance the transdermal delivery of many macromolecules[1].
• Target Antigen: Na+/K+ ATPase
• Type: Peptides
• Related Pathways: Membrane Transporter/Ion Channel
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/transdermal-peptide-tfa.html
• Purity: 98.86
• Solubility: H2O : 100 mg/mL (ultrasonic)
• Smiles: O=C1N2[C@@](C(N[C@H](C(N[C@@](C(N[C@H](C(N[C@H](C(NCC(O)=O)=O)CSSC[C@H](NC([C@@H](N)C)=O)C(N[C@H](CO)C(N[C@@H](CO)C(N[C@@]1([H])CO)=O)=O)=O)=O)CC3=CN=CN3)=O)([H])CCCCN)=O)CO)=O)([H])CCC2.O=C(O)C(F)(F)F
• Molecular Weight: 1175.17
• References & Citations: [1]Wang C, et al. Role of the Na(+)/K(+)-ATPase beta-subunit in peptide-mediated transdermal drug delivery. Mol Pharm. 2015 Apr 6;12(4):1259-67.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported